Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

45.3K
Overview
45.3K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

314
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
314
Cross-reactivity00:42

Cross-reactivity

31.5K
Overview
31.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comparative analysis of the immunotranscriptomic features of DENV-1, -3, and -4 human challenge models.

The Journal of infectious diseases·2026
Same author

Long-term antibody dynamics challenge the paradigm of lifelong homotypic immunity to dengue virus.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Addressing the elephant in the room: Proceedings of the third annual Dengue Endgame Summit.

PLoS neglected tropical diseases·2026
Same author

Inactivated Japanese encephalitis virus vaccination imprints fusion loop-biased antibody responses that are attenuated by repeated live-attenuated dengue vaccination.

medRxiv : the preprint server for health sciences·2026
Same author

Humoral and cellular responses to a tetravalent dengue vaccine (TAK-003) in adults from a dengue non-endemic region: An open-label phase 2 trial.

Vaccine·2026
Same author

Early individualized risk prediction using clinical data for children during the febrile phase of dengue in outpatient settings in Vietnam and Thailand.

PLOS digital health·2026

Related Experiment Video

Updated: Sep 11, 2025

A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum
07:06

A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum

Published on: April 10, 2018

8.9K

Dengue Fever Vaccines: Progress and Challenges.

Alan L Rothman1, Heather Friberg2

  • 1Institute for Immunology and Informatics, Department of Cell and Molecular Biology, University of Rhode Island, Kingston, Rhode Island, USA;

Annual Review of Pharmacology and Toxicology
|August 18, 2025
PubMed
Summary
This summary is machine-generated.

Developing effective dengue vaccines remains challenging despite decades of research. Overcoming viral serotypes and immune complexities is crucial for next-generation dengue vaccine success.

Keywords:
dengueimmune enhancementvaccine

More Related Videos

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

6.7K
Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction
08:36

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction

Published on: November 1, 2018

32.1K

Related Experiment Videos

Last Updated: Sep 11, 2025

A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum
07:06

A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum

Published on: April 10, 2018

8.9K
A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

6.7K
Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction
08:36

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction

Published on: November 1, 2018

32.1K

Area of Science:

  • * Virology and Immunology
  • * Vaccine Development and Clinical Trials

Background:

  • * Dengue vaccine development has been a priority for over 75 years.
  • * Significant progress includes Phase III trials and licensing of several dengue vaccines in the last 15 years.
  • * A universally suitable dengue vaccine for broad use has not yet been achieved.

Purpose of the Study:

  • * To review the progress and persistent challenges in dengue vaccine development.
  • * To identify key scientific obstacles hindering the creation of a broadly effective dengue vaccine.
  • * To outline future research needs for next-generation dengue vaccines.

Main Methods:

  • * Review of historical and current dengue vaccine research and clinical trial data.
  • * Analysis of scientific literature on dengue viral characteristics and host immune responses.
  • * Identification of immunological factors complicating vaccine efficacy.

Main Results:

  • * Multiple dengue vaccines have reached advanced trial stages and licensing.
  • * Significant scientific hurdles persist, including dengue virus serotypes, immune imprinting, and antibody-dependent enhancement.
  • * Current vaccines may not be suitable for all populations or endemic settings.

Conclusions:

  • * Further investment in clinical research of natural dengue virus infections is essential.
  • * Understanding participant responses in dengue vaccine trials is critical.
  • * Continued research is necessary to develop and test improved dengue vaccines.